Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 28, 2010Human Gene TherapyOpen Access

Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

LSLuc SensebéCentre National de la Recherche ScientifiquePBPhilippe BourinUnited States Nuclear Regulatory CommissionKTKarin TarteInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sensebé et al. (2010) studied this question.

synapsesocial.com/papers/69dd62397808b00a4799d741https://doi.org/10.1089/hum.2010.197
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy2000 · 1,119 citations
  2. 2Specific Lineage-Priming of Bone Marrow Mesenchymal Stem Cells Provides the Molecular Framework for Their Plasticity2009 · 129 citations
  3. 3Bmi1, stem cells, and senescence regulation2004 · 425 citations
  4. 4Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue2006 · 3,434 citations
  5. 5Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals2003 · 1,167 citations